Search This Blog

Wednesday, March 5, 2014

U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin (NYSE:LLY)

U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.